The landscape of TIGIT target and clinical application in diseases

The landscape of TIGIT target and clinical application in diseases

Abstract Immune checkpoint blockade has dramatically altered the concept of cancer therapeutics over the past few years. Beyond the existing classical pathways, novel immune checkpoints, such as T‐cell immunoglobulin and immunoreceptor tyrosine‐based inhibitory motif (ITIM) structural domain (TIGIT)...

Full description

Bibliographic Details
Main Authors: Shu Rui, Xiangyu Kong, Jiaye Liu, Liying Wang, Xiaofei Wang, Xiuhe Zou, Xun Zheng, Feng Ye, Heng Xu, Zhihui Li, Han Luo
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:MedComm – Oncology
Subjects:
autoimmune disease
chronic infection
COVID‐19‐introduction
immune checkpoint blockade
malignancy
TIGIT
Online Access:https://doi.org/10.1002/mog2.18

Internet

https://doi.org/10.1002/mog2.18

Similar Items